Home / Recalls / Heritage Pharmaceuticals, Inc. / D-1065-2019

D-1065-2019 Class II Terminated

Recalled by Heritage Pharmaceuticals, Inc. — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
March 27, 2019
Initiation Date
February 15, 2019
Termination Date
March 4, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11888 units

Product Description

Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage Pharmaceuticals Inc. Made in India, NDC 23155-160-31

Reason for Recall

Subpotent Drug.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: AMA701, Exp. March 2019; AMA702, AMA703, Exp August 2019.

Other recalls by Heritage Pharmaceuticals, Inc.

  • D-0108-2026 Class II — Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-0 (October 6, 2025)
  • D-0112-2026 Class II — Desipramine Hydrochloride Tablets, USP, 150 mg, 50 count bottle (NDC 23155-583-2 (October 6, 2025)
  • D-0110-2026 Class II — Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-0 (October 6, 2025)
  • D-0111-2026 Class II — Desipramine Hydrochloride Tablets, USP, 100 mg, 100 count bottle (NDC 23155-582- (October 6, 2025)
  • D-0107-2026 Class II — Desipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578 (October 6, 2025)
  • D-0109-2026 Class II — Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-0 (October 6, 2025)
  • D-0072-2023 Class II — Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: (November 23, 2022)
  • D-0367-2021 Class III — Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharm (April 21, 2021)
  • D-0108-2021 Class III — Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distri (October 23, 2020)
  • D-1398-2019 Class I — AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mf (May 21, 2019)